Coexpression cluster:C211
From FANTOM5_SSTAR
Full id: C211_small_Hepatocyte_liver_colon_temporal_duodenum_kidney
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
1.15247210510591e-06 | 0.000243171614177346 | 4 | 59 | Arachidonic acid metabolism (KEGG):00590 |
7.13397324646485e-08 | 4.51580506501225e-05 | 4 | 30 | Linoleic acid metabolism (KEGG):00591 |
8.57251743419267e-05 | 0.00678300441980495 | 3 | 64 | Retinol metabolism (KEGG):00830 |
0.000116845126210202 | 0.00767359370758104 | 3 | 71 | Metabolism of xenobiotics by cytochrome P450 (KEGG):00980 |
0.000126917500912663 | 0.00767359370758104 | 3 | 73 | Drug metabolism - cytochrome P450 (KEGG):00982 |
4.59754408998177e-05 | 0.00485040901493076 | 3 | 52 | Drug metabolism - other enzymes (KEGG):00983 |
1.72073339083583e-07 | 5.44612118199539e-05 | 11 | 1138 | Metabolic pathways (KEGG):01100 |
0.000154530311543426 | 0.00815147393391574 | 3 | 78 | Peroxisome (KEGG):04146 |
0.000998589478845497 | 0.0371827729476 | 2 | 35 | Fluoropyrimidine Activity (Wikipathways):WP1601 |
0.000133348389863178 | 0.00767359370758104 | 2 | 13 | Irinotecan Pathway (Wikipathways):WP229 |
0.000887631566171946 | 0.0351169238366776 | 2 | 33 | Nuclear receptors in lipid metabolism and toxicity (Wikipathways):WP299 |
7.42549874428589e-05 | 0.00671477243590424 | 3 | 61 | cytochrome P450 (Wikipathways):WP43 |
3.60830331719628e-05 | 0.00456811199957049 | 2 | 7 | Arachidonate Epoxygenase / Epoxide Hydrolase (Wikipathways):WP678 |
0.00029087055301572 | 0.0141631584660731 | 2 | 19 | Tamoxifen metabolism (Wikipathways):WP691 |
3.48380348952018e-06 | 0.000551311902216568 | 5 | 175 | metapathway biotransformation (Wikipathways):WP702 |
0.000579134600002315 | 0.0261851572715332 | 4 | 289 | Metabolism of lipids and lipoproteins (Reactome):REACT_22258 |
0.000692868648311646 | 0.0292390569587515 | 3 | 130 | Biological oxidations (Reactome):REACT_13433 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0005783 | endoplasmic reticulum | 0.000166232769863203 |
GO:0044255 | cellular lipid metabolic process | 0.000292195308455164 |
GO:0006629 | lipid metabolic process | 0.000767639703596833 |
GO:0044444 | cytoplasmic part | 0.000767639703596833 |
GO:0032787 | monocarboxylic acid metabolic process | 0.00101187401991179 |
GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 0.00101187401991179 |
GO:0044432 | endoplasmic reticulum part | 0.00101187401991179 |
GO:0019752 | carboxylic acid metabolic process | 0.00101187401991179 |
GO:0006082 | organic acid metabolic process | 0.00101187401991179 |
GO:0006631 | fatty acid metabolic process | 0.00254640139128139 |
GO:0005737 | cytoplasm | 0.00548687314804639 |
GO:0005777 | peroxisome | 0.00651008947141174 |
GO:0042579 | microbody | 0.00651008947141174 |
GO:0050381 | unspecific monooxygenase activity | 0.0127585701205273 |
GO:0042221 | response to chemical stimulus | 0.0127585701205273 |
GO:0006091 | generation of precursor metabolites and energy | 0.0134364792462607 |
GO:0006805 | xenobiotic metabolic process | 0.015055976095265 |
GO:0009410 | response to xenobiotic stimulus | 0.0160201134498307 |
GO:0008374 | O-acyltransferase activity | 0.0160201134498307 |
GO:0005792 | microsome | 0.0160201134498307 |
GO:0042598 | vesicular fraction | 0.0160201134498307 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 0.0160201134498307 |
GO:0031090 | organelle membrane | 0.0160201134498307 |
GO:0043651 | linoleic acid metabolic process | 0.0160201134498307 |
GO:0008391 | arachidonic acid monooxygenase activity | 0.0160201134498307 |
GO:0009348 | ornithine carbamoyltransferase complex | 0.0160201134498307 |
GO:0033791 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity | 0.0160201134498307 |
GO:0003869 | 4-nitrophenylphosphatase activity | 0.0160201134498307 |
GO:0004092 | carnitine O-acetyltransferase activity | 0.0160201134498307 |
GO:0002532 | production of molecular mediator of acute inflammatory response | 0.0160201134498307 |
GO:0008392 | arachidonic acid epoxygenase activity | 0.0160201134498307 |
GO:0004585 | ornithine carbamoyltransferase activity | 0.0160201134498307 |
GO:0002539 | prostaglandin production during acute inflammatory response | 0.0160201134498307 |
GO:0002538 | production of arachidonic acid metabolites during acute inflammatory response | 0.0160201134498307 |
GO:0005789 | endoplasmic reticulum membrane | 0.0200455236898233 |
GO:0042175 | nuclear envelope-endoplasmic reticulum network | 0.020781869242664 |
GO:0019825 | oxygen binding | 0.020781869242664 |
GO:0008202 | steroid metabolic process | 0.020781869242664 |
GO:0044262 | cellular carbohydrate metabolic process | 0.020781869242664 |
GO:0031667 | response to nutrient levels | 0.020781869242664 |
GO:0004497 | monooxygenase activity | 0.020781869242664 |
GO:0042493 | response to drug | 0.020781869242664 |
GO:0005788 | endoplasmic reticulum lumen | 0.020781869242664 |
GO:0016139 | glycoside catabolic process | 0.020781869242664 |
GO:0018675 | (S)-limonene 6-monooxygenase activity | 0.020781869242664 |
GO:0018676 | (S)-limonene 7-monooxygenase activity | 0.020781869242664 |
GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity | 0.020781869242664 |
GO:0033767 | 4-hydroxyacetophenone monooxygenase activity | 0.020781869242664 |
GO:0015788 | UDP-N-acetylglucosamine transport | 0.020781869242664 |
GO:0019113 | limonene monooxygenase activity | 0.020781869242664 |
GO:0016137 | glycoside metabolic process | 0.020781869242664 |
GO:0017159 | pantetheinase activity | 0.020781869242664 |
GO:0015293 | symporter activity | 0.020781869242664 |
GO:0009991 | response to extracellular stimulus | 0.0213609920965642 |
GO:0000267 | cell fraction | 0.0232283299567552 |
GO:0016020 | membrane | 0.0237885008900423 |
GO:0044446 | intracellular organelle part | 0.0245242466769064 |
GO:0044422 | organelle part | 0.0245716351347396 |
GO:0016413 | O-acetyltransferase activity | 0.0267601407488756 |
GO:0004146 | dihydrofolate reductase activity | 0.0267601407488756 |
GO:0008422 | beta-glucosidase activity | 0.0267601407488756 |
GO:0009056 | catabolic process | 0.0284975497610938 |
GO:0020037 | heme binding | 0.0284975497610938 |
GO:0046906 | tetrapyrrole binding | 0.0284975497610938 |
GO:0008652 | amino acid biosynthetic process | 0.0284975497610938 |
GO:0005351 | sugar:hydrogen ion symporter activity | 0.0319907438174286 |
GO:0045909 | positive regulation of vasodilation | 0.0319907438174286 |
GO:0006545 | glycine biosynthetic process | 0.0319907438174286 |
GO:0012505 | endomembrane system | 0.0323882090546499 |
GO:0051119 | sugar transmembrane transporter activity | 0.0336469325662541 |
GO:0015144 | carbohydrate transmembrane transporter activity | 0.0345462005428184 |
GO:0017110 | nucleoside-diphosphatase activity | 0.0357711277698788 |
GO:0015781 | pyrimidine nucleotide-sugar transport | 0.0357711277698788 |
GO:0010043 | response to zinc ion | 0.0357711277698788 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 0.0357711277698788 |
GO:0005543 | phospholipid binding | 0.0357711277698788 |
GO:0006807 | nitrogen compound metabolic process | 0.0362188514416722 |
GO:0005624 | membrane fraction | 0.0362188514416722 |
GO:0008643 | carbohydrate transport | 0.0362188514416722 |
GO:0015165 | pyrimidine nucleotide sugar transmembrane transporter activity | 0.0362188514416722 |
GO:0046688 | response to copper ion | 0.0362188514416722 |
GO:0003997 | acyl-CoA oxidase activity | 0.0362188514416722 |
GO:0004301 | epoxide hydrolase activity | 0.0362188514416722 |
GO:0016406 | carnitine O-acyltransferase activity | 0.0362188514416722 |
GO:0004463 | leukotriene-A4 hydrolase activity | 0.0362188514416722 |
GO:0042301 | phosphate binding | 0.0362188514416722 |
GO:0042312 | regulation of vasodilation | 0.0362188514416722 |
GO:0016743 | carboxyl- or carbamoyltransferase activity | 0.0362188514416722 |
GO:0008385 | IkappaB kinase complex | 0.0362188514416722 |
GO:0017144 | drug metabolic process | 0.0362188514416722 |
GO:0015291 | secondary active transmembrane transporter activity | 0.0363783846269499 |
GO:0043231 | intracellular membrane-bound organelle | 0.0363783846269499 |
GO:0043227 | membrane-bound organelle | 0.0363783846269499 |
GO:0046983 | protein dimerization activity | 0.0371343714481092 |
GO:0015980 | energy derivation by oxidation of organic compounds | 0.0371343714481092 |
GO:0006118 | electron transport | 0.0375783309344986 |
GO:0009309 | amine biosynthetic process | 0.0375783309344986 |
GO:0044424 | intracellular part | 0.0401485454015201 |
GO:0030299 | cholesterol absorption | 0.0409602751002365 |
GO:0019627 | urea metabolic process | 0.0409602751002365 |
GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 0.0409602751002365 |
GO:0000050 | urea cycle | 0.0409602751002365 |
GO:0044241 | lipid digestion | 0.0409602751002365 |
GO:0004332 | fructose-bisphosphate aldolase activity | 0.0409602751002365 |
GO:0043603 | amide metabolic process | 0.0409602751002365 |
GO:0016803 | ether hydrolase activity | 0.0409602751002365 |
GO:0015307 | drug:hydrogen antiporter activity | 0.0447889839759333 |
GO:0015904 | tetracycline transport | 0.0447889839759333 |
GO:0015520 | tetracycline:hydrogen antiporter activity | 0.0447889839759333 |
GO:0044464 | cell part | 0.0447961671487045 |
GO:0005975 | carbohydrate metabolic process | 0.0455601062325889 |
GO:0015101 | organic cation transmembrane transporter activity | 0.0455601062325889 |
GO:0050892 | intestinal absorption | 0.0455601062325889 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 0.0455601062325889 |
GO:0046677 | response to antibiotic | 0.0455601062325889 |
GO:0008493 | tetracycline transporter activity | 0.0455601062325889 |
GO:0045777 | positive regulation of blood pressure | 0.0455601062325889 |
GO:0042895 | antibiotic transporter activity | 0.0455601062325889 |
GO:0031941 | filamentous actin | 0.0455601062325889 |
GO:0044271 | nitrogen compound biosynthetic process | 0.0455741786853529 |
GO:0043229 | intracellular organelle | 0.046614361628882 |
GO:0043226 | organelle | 0.046614361628882 |
GO:0000186 | activation of MAPKK activity | 0.0476859990628521 |
GO:0009070 | serine family amino acid biosynthetic process | 0.0476859990628521 |
GO:0004565 | beta-galactosidase activity | 0.0476859990628521 |
GO:0000287 | magnesium ion binding | 0.047781640586173 |
GO:0042803 | protein homodimerization activity | 0.0494110712844477 |
GO:0008015 | blood circulation | 0.0496129124709751 |
GO:0003013 | circulatory system process | 0.0496129124709751 |
GO:0051384 | response to glucocorticoid stimulus | 0.0496129124709751 |
GO:0015925 | galactosidase activity | 0.0496129124709751 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
metabolising cell | 1.12e-23 | 12 |
endopolyploid cell | 1.12e-23 | 12 |
parenchymal cell | 1.12e-23 | 12 |
polyploid cell | 1.12e-23 | 12 |
hepatocyte | 1.12e-23 | 12 |
endodermal cell | 9.78e-08 | 58 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.00239411 |
MA0004.1 | 0.138771 |
MA0006.1 | 0.026133 |
MA0007.1 | 0.964995 |
MA0009.1 | 0.508818 |
MA0014.1 | 0.000582734 |
MA0017.1 | 12.0045 |
MA0019.1 | 0.337248 |
MA0024.1 | 1.21715 |
MA0025.1 | 0.25504 |
MA0027.1 | 1.59503 |
MA0028.1 | 0.164541 |
MA0029.1 | 1.85768 |
MA0030.1 | 2.44897 |
MA0031.1 | 2.11546 |
MA0038.1 | 0.11044 |
MA0040.1 | 0.400295 |
MA0041.1 | 0.538204 |
MA0042.1 | 0.00871925 |
MA0043.1 | 0.509267 |
MA0046.1 | 1.52294 |
MA0048.1 | 0.0775153 |
MA0050.1 | 1.33854 |
MA0051.1 | 0.489427 |
MA0052.1 | 0.129261 |
MA0055.1 | 0.3399 |
MA0056.1 | 0 |
MA0057.1 | 0.227015 |
MA0058.1 | 0.254524 |
MA0059.1 | 0.0577193 |
MA0060.1 | 0.0973813 |
MA0061.1 | 0.173259 |
MA0063.1 | 0 |
MA0066.1 | 0.268418 |
MA0067.1 | 0.390744 |
MA0068.1 | 0.13906 |
MA0069.1 | 0.162157 |
MA0070.1 | 0.47244 |
MA0071.1 | 0.674702 |
MA0072.1 | 0.909449 |
MA0073.1 | 0.00035895 |
MA0074.1 | 0.106914 |
MA0076.1 | 0.0221401 |
MA0077.1 | 0.149129 |
MA0078.1 | 0.0507386 |
MA0081.1 | 0.252203 |
MA0083.1 | 0.17499 |
MA0084.1 | 0.545308 |
MA0087.1 | 0.46286 |
MA0088.1 | 0.380625 |
MA0089.1 | 0 |
MA0090.1 | 0.176289 |
MA0091.1 | 1.42807 |
MA0092.1 | 1.2077 |
MA0093.1 | 0.0701154 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.120599 |
MA0101.1 | 0.148906 |
MA0103.1 | 0.985634 |
MA0105.1 | 0.0132555 |
MA0106.1 | 0.330986 |
MA0107.1 | 0.197713 |
MA0108.2 | 0.615972 |
MA0109.1 | 0 |
MA0111.1 | 0.559463 |
MA0113.1 | 1.42405 |
MA0114.1 | 18.6292 |
MA0115.1 | 5.36139 |
MA0116.1 | 0.649993 |
MA0117.1 | 0.193003 |
MA0119.1 | 0.368305 |
MA0122.1 | 0.209091 |
MA0124.1 | 0.301544 |
MA0125.1 | 0.242948 |
MA0130.1 | 0 |
MA0131.1 | 0.206843 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.188602 |
MA0136.1 | 0.278172 |
MA0139.1 | 0.140928 |
MA0140.1 | 0.083025 |
MA0141.1 | 2.67375 |
MA0142.1 | 0.263523 |
MA0143.1 | 0.155936 |
MA0144.1 | 0.918413 |
MA0145.1 | 1.04581 |
MA0146.1 | 0.208228 |
MA0147.1 | 0.00220865 |
MA0148.1 | 0.330855 |
MA0149.1 | 1.31278 |
MA0062.2 | 0.0261786 |
MA0035.2 | 0.404395 |
MA0039.2 | 0.0749215 |
MA0138.2 | 1.14111 |
MA0002.2 | 0.138005 |
MA0137.2 | 0.468293 |
MA0104.2 | 0.000494081 |
MA0047.2 | 0.311759 |
MA0112.2 | 0.531624 |
MA0065.2 | 3.51526 |
MA0150.1 | 0.16784 |
MA0151.1 | 0 |
MA0152.1 | 0.687022 |
MA0153.1 | 1.89841 |
MA0154.1 | 0.160196 |
MA0155.1 | 0.00865997 |
MA0156.1 | 0.179316 |
MA0157.1 | 0.867142 |
MA0158.1 | 0 |
MA0159.1 | 0.126567 |
MA0160.1 | 0.601688 |
MA0161.1 | 0 |
MA0162.1 | 1.29808e-07 |
MA0163.1 | 0.0312518 |
MA0164.1 | 0.674303 |
MA0080.2 | 0.0273277 |
MA0018.2 | 0.0359876 |
MA0099.2 | 0.21979 |
MA0079.2 | 2.03195e-05 |
MA0102.2 | 0.577493 |
MA0258.1 | 0.845722 |
MA0259.1 | 0.000322258 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
ESRRA#2101 | 2 | 13.8240089753179 | 0.0093777714259441 | 0.0353895237562485 |
FOXA1#3169 | 17 | 2.69120193913647 | 0.000127401571527303 | 0.00169477680916317 |
FOXA2#3170 | 14 | 4.92609275053305 | 7.37113804995693e-07 | 3.27032407306479e-05 |
HDAC2#3066 | 14 | 2.68312404732525 | 0.000580923925217827 | 0.00487396479963244 |
HEY1#23462 | 39 | 2.25091900973032 | 3.14827382705494e-08 | 2.12267637329755e-06 |
HNF4A#3172 | 26 | 8.5919935633828 | 5.65805065981129e-18 | 1.24666909886082e-15 |
HNF4G#3174 | 27 | 11.0906058316295 | 1.6553354100915e-21 | 4.47879727706078e-19 |
RXRA#6256 | 13 | 3.72814318298189 | 3.77401043834215e-05 | 0.0007230854451844 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data